Any old ion? Metrion gets grant to develop better stem cell-based cardiac risk assays – OutSourcing-Pharma.com
OutSourcing-Pharma.com |
Any old ion? Metrion gets grant to develop better stem cell-based cardiac risk assays
OutSourcing-Pharma.com The idea is to use Nanion's CardioExcyte96 platform, which enables simultaneous recording of cardiac cell electrical activity and contractility, to develop compliant cardiac safety assays using human iPSC-derived cardiomyocytes provided by the Leiden … |
